Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth
"In recent years, Lilly has transformed our research engine, sped development, and launched breakthrough medicines while dramatically expanding production capacity and improving access to care and affordability," said Ricks. "Looking ahead, we see an even greater opportunity to help people live better lives and grow our company and its impact. To enable this exciting future, we're adding two exceptional leaders in Carole and Adrienne to drive our expansion plans in neuroscience and immunology, and we're exp ...